| Line Item | 2025-09-30 | Q/Q | Y/Y |
|---|---|---|---|
| R&D Expense | $7.5M | -47.5% | -73.6% |
| SG&A Expense | $4.5M | -24.6% | -29.4% |
| Operating Income | $1.1M | +106.4% | +103.1% |
| Pre-tax Income | $3.4M | +120.6% | +110.0% |
| Income Tax | $145K | -41.5% | -70.1% |
| Net Income | $3.3M | +119.5% | +109.5% |
| EPS (Basic) | $0.08 | +120.5% | +109.9% |
| EPS (Diluted) | $0.08 | +120.5% | +109.9% |
| Line Item | 2025-09-30 | Q/Q | Y/Y |
|---|---|---|---|
| Cash & Equivalents | $72.8M | +7.6% | -9.6% |
| Short-term Investments | $39.8M | -4.9% | -59.8% |
| Current Assets | $124.4M | -1.7% | -37.9% |
| Total Assets | $126.7M | -2.9% | -38.6% |
| Current Liabilities | $11.6M | -42.1% | -62.6% |
| Total Liabilities |
| Line Item | 2025-09-30 | Q/Q | Y/Y |
|---|---|---|---|
| Operating Cash Flow | -$42.8M | — | — |
| Investing Cash Flow | $30.7M | — | — |
| Financing Cash Flow | $109K | — | — |
| $11.6M |
| -42.1% |
| -63.0% |
| Stockholders' Equity | $115.1M | +4.3% | -34.2% |